表 1.
SLE患者的基本资料
Demographics characteristics of SLE patients
| Parameters | SLE (n=107) |
| SLE, systemic lupus erythematosus; Anti-dsDNA, anti-double-stranded DNA; Anti-Sm, anti-Smith; GC, glucocorticoid; HCQ, hydroxychloroquine; MMF, mycophenolate mofetil; CTX, cyclophosphamide; RTX, rituximab. | |
| Age/years, M (P25, P75) | 31 (25, 34) |
| Disease duration/years, M (P25, P75) | 4 (1, 10) |
| Rash, n (%) | 64 (59.8) |
| Photosensitivity, n (%) | 18 (16.8) |
| Oral ulcers, n (%) | 17 (15.9) |
| Arthritis, n (%) | 62 (57.9) |
| Serositis, n (%) | 31 (29.0) |
| Renal disorder, n (%) | 54 (50.5) |
| Neurologic disorder, n (%) | 30 (28.0) |
| Hematologic disorder, n (%) | 54 (50.5) |
| Antinuclear antibody positive, n (%) | 101 (94.4) |
| Anti-dsDNA antibody positive, n (%) | 66 (60.7) |
| Anti-Sm antibody positive, n (%) | 19 (17.8) |
| GC, n (%) | 74 (69.1) |
| HCQ, n (%) | 69 (64.5) |
| MMF, n (%) | 45 (42.1) |
| CTX, n (%) | 5 (4.7) |
| RTX, n (%) | 20 (18.7) |
| Telitacicept, n (%) | 19 (17.8) |